Data Sharing in Pharmaceutical Supply Chains - Case European Medicines Verification System
Loading...
Access rights
openAccess
publishedVersion
URL
Journal Title
Journal ISSN
Volume Title
A3 Kirjan tai muun kokoomateoksen osa
This publication is imported from Aalto University research portal.
View publication in the Research portal (opens in new window)
View/Open full text file from the Research portal (opens in new window)
Other link related to publication (opens in new window)
View publication in the Research portal (opens in new window)
View/Open full text file from the Research portal (opens in new window)
Other link related to publication (opens in new window)
Date
2020-06-26
Major/Subject
Mcode
Degree programme
Language
en
Pages
4
Series
Studies in Health Technology and Informatics ; Volume 272
Abstract
We study the perceived value derived from data sharing activities by the representatives of a Nordic pharmaceutical company in the introduction of the European Medicines Verification System (EMVS). The system is an end-to-end verification protocol that would potentially enable the pharmaceutical companies to access the sales-point data from within the system, while maintaining the control of their own data. The benefits of the system are most notably in developing data sharing with the wholesalers and end-customers. Development of data sharing practices might enable more transparent logistics, and more targeted services and products.Description
Keywords
Data Sharing, European Medicines Verification System, Pharmaceutical Industry, Supply Chains
Other note
Citation
Levänen, L, Halminen, O, Tenhunen, H & Seppälä, T 2020, Data Sharing in Pharmaceutical Supply Chains - Case European Medicines Verification System . in The Importance of Health Informatics in Public Health during a Pandemic . Studies in Health Technology and Informatics, vol. 272, IOS Press, pp. 276-279 . https://doi.org/10.3233/SHTI200548